A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology. - Frisell O; Aas E; Henkel PS; Fagereng GL; Taskén K; Hallersjö Hult E; Lindgren P; Steen Carlsson K (Acta oncologica (Stockholm, Sweden), 2026)